SCHEMBL2562008

SCHEMBL2562008

CCOC(=O)C=Cc1ccc(OCC)c2oc3cnccc3c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 5/20 0.42
CDK8 P49336 5/20 0.42
CDK19 Q9BWU1 1/20 0.40
BRAF P15056 4/20 0.38
EIF2AK3 Q9NZJ5 3/20 0.38
FDPS P14324 1/20 0.36
CYP3A4 P08684 1/20 0.36
NPC1 O15118 1/20 0.36
CASP3 P42574 1/20 0.36
RAB9A P51151 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
DPP4 P27487 1/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2562005 1.00 CCNC (0.42) CCNCCDK8CDK19BRAFEIF2AK3
SCHEMBL2556731 0.92 CCNC (0.42) CCNCCDK8CDK19BRAFEIF2AK3
SCHEMBL2557438 0.90 CCNC (0.38) CCNCCDK8CDK19BRAFEIF2AK3
SCHEMBL2557440 0.90 CCNC (0.38) CCNCCDK8CDK19BRAFEIF2AK3
SCHEMBL2562733 0.90 KDM4E (0.39) CCNCCDK8BRAFEIF2AK3CYP19A1
SCHEMBL2562731 0.90 KDM4E (0.39) CCNCCDK8BRAFEIF2AK3CYP19A1
SCHEMBL2563026 0.88 CCNC (0.40) CCNCCDK8CDK19BRAFEIF2AK3
SCHEMBL2559729 0.88 CCNC (0.44) CCNCCDK8CDK19BRAFEIF2AK3
SCHEMBL2559731 0.88 CCNC (0.44) CCNCCDK8CDK19BRAFEIF2AK3
SCHEMBL2563005 0.84 CCNC (0.42) CCNCCDK8CDK19FDPSCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO disclosed